149 related articles for article (PubMed ID: 17327464)
1. Identification of essential histidine and cysteine residues of the H+/organic cation antiporter multidrug and toxin extrusion (MATE).
Asaka J; Terada T; Tsuda M; Katsura T; Inui K
Mol Pharmacol; 2007 Jun; 71(6):1487-93. PubMed ID: 17327464
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.
Masuda S; Terada T; Yonezawa A; Tanihara Y; Kishimoto K; Katsura T; Ogawa O; Inui K
J Am Soc Nephrol; 2006 Aug; 17(8):2127-35. PubMed ID: 16807400
[TBL] [Abstract][Full Text] [Related]
3. Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1.
Tsuda M; Terada T; Asaka J; Ueba M; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F593-8. PubMed ID: 17047166
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of diethyl pyrocarbonate on the H+/organic cation antiport system in rat renal brush-border membranes.
Hori R; Maegawa H; Kato M; Katsura T; Inui K
J Biol Chem; 1989 Jul; 264(21):12232-7. PubMed ID: 2745439
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.
Matsuzaki T; Morisaki T; Sugimoto W; Yokoo K; Sato D; Nonoguchi H; Tomita K; Terada T; Inui K; Hamada A; Saito H
Drug Metab Dispos; 2008 Apr; 36(4):649-54. PubMed ID: 18180268
[TBL] [Abstract][Full Text] [Related]
6. Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney.
Ohta KY; Inoue K; Hayashi Y; Yuasa H
Drug Metab Dispos; 2006 Nov; 34(11):1868-74. PubMed ID: 16928787
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.
Terada T; Masuda S; Asaka J; Tsuda M; Katsura T; Inui K
Pharm Res; 2006 Aug; 23(8):1696-701. PubMed ID: 16850272
[TBL] [Abstract][Full Text] [Related]
8. Functional characteristics of two human MATE transporters: kinetics of cimetidine transport and profiles of inhibition by various compounds.
Ohta KY; Inoue K; Yasujima T; Ishimaru M; Yuasa H
J Pharm Pharm Sci; 2009; 12(3):388-96. PubMed ID: 20067714
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of multidrug and toxin extrusion protein 1 as a facilitative transporter for fluoroquinolones.
Ohta KY; Imamura Y; Okudaira N; Atsumi R; Inoue K; Yuasa H
J Pharmacol Exp Ther; 2009 Feb; 328(2):628-34. PubMed ID: 19004926
[TBL] [Abstract][Full Text] [Related]
10. Distinct transport activity of tetraethylammonium from L-carnitine in rat renal brush-border membranes.
Ohnishi S; Saito H; Fukada A; Inui K
Biochim Biophys Acta; 2003 Jan; 1609(2):218-24. PubMed ID: 12543384
[TBL] [Abstract][Full Text] [Related]
11. Purification and reconstitution of polyspecific H
Kawasaki T; Matsumoto T; Iwai Y; Kawakami M; Juge N; Omote H; Nabekura T; Moriyama Y
Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2456-2464. PubMed ID: 30028956
[TBL] [Abstract][Full Text] [Related]
12. Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity.
Kajiwara M; Terada T; Ogasawara K; Iwano J; Katsura T; Fukatsu A; Doi T; Inui K
J Hum Genet; 2009 Jan; 54(1):40-6. PubMed ID: 19158817
[TBL] [Abstract][Full Text] [Related]
13. Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters.
Kajiwara M; Masuda S; Watanabe S; Terada T; Katsura T; Inui K
Drug Metab Pharmacokinet; 2012; 27(6):563-9. PubMed ID: 22510868
[TBL] [Abstract][Full Text] [Related]
14. Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats.
Shi R; Yang Y; Xu Z; Dai Y; Zheng M; Wang T; Li Y; Ma Y
Biopharm Drug Dispos; 2018 Jan; 39(1):47-58. PubMed ID: 29065218
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters.
Tanihara Y; Masuda S; Sato T; Katsura T; Ogawa O; Inui K
Biochem Pharmacol; 2007 Jul; 74(2):359-71. PubMed ID: 17509534
[TBL] [Abstract][Full Text] [Related]
16. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.
Motohashi H; Inui K
Mol Aspects Med; 2013; 34(2-3):661-8. PubMed ID: 23506899
[TBL] [Abstract][Full Text] [Related]
17. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
[TBL] [Abstract][Full Text] [Related]
18. Identification of essential histidine residues in 3-deoxy-D-manno-octulosonic acid 8-phosphate synthase: analysis by chemical modification with diethyl pyrocarbonate and site-directed mutagenesis.
Sheflyan GY; Duewel HS; Chen G; Woodard RW
Biochemistry; 1999 Oct; 38(43):14320-9. PubMed ID: 10572007
[TBL] [Abstract][Full Text] [Related]
19. His257 is a uniquely important histidine residue for tetracycline/H+ antiport function but not mandatory for full activity of the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
Yamaguchi A; Samejima T; Kimura T; Sawai T
Biochemistry; 1996 Apr; 35(14):4359-64. PubMed ID: 8605184
[TBL] [Abstract][Full Text] [Related]
20. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).
Terada T; Inui K
Biochem Pharmacol; 2008 May; 75(9):1689-96. PubMed ID: 18262170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
